Whole-exome sequencing identification of novel DNAH5 mutations in a young patient with primary ciliary dyskinesia

Gen Kano1, Hisashi Tsujii1, Kazuhiko Takeuchi2

  • 1Department of Pediatrics, Kyoto‑Yamashiro General Medical Center, Kizugawashi, Kyoto 619‑0214, Japan.

Insights

Primary ciliary dyskinesia (PCD) is a rare genetic disorder. This study reports the first Japanese case of PCD caused by novel DNAH5 mutations, highlighting diagnostic challenges.

Area of Science:

  • Genetics
  • Pulmonology
  • Rare Diseases

Background:

  • Primary ciliary dyskinesia (PCD) is a rare genetic disorder affecting cilia function, leading to chronic respiratory and ear issues.
  • Early diagnosis is crucial for managing PCD, but phenotypic heterogeneity poses a significant challenge.

Observation:

  • A 9-year-old patient presented with chronic cough, recurrent pneumonia, sinusitis, and otitis media with effusion, but no situs inversus.
  • Chest imaging revealed persistent right middle lobe atelectasis and bronchiectasis.
  • Nasal cilia electron microscopy showed loss of outer dynein arms.

Findings:

  • Whole-exome sequencing identified compound heterozygous mutations in DNAH5 (NM_001369.2:c.5983C>T and NM_001369.2:c.9101delG).
  • These DNAH5 mutations are novel and previously unreported in Japanese patients.
  • This represents the first reported case of PCD attributed to DNAH5 mutations in a Japanese individual.

Implications:

  • This case underscores the importance of advanced diagnostics like electron microscopy and genetic analysis for PCD diagnosis.
  • Identifying novel mutations expands the known genetic landscape of PCD, particularly in diverse populations.
  • Further research into DNAH5 mutations can improve diagnostic strategies and understanding of PCD pathogenesis.